Posted on 4/30/19
Genocea Provides Corporate Update
CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today reported its operating and financial . . .
Posted on 4/30/19
Akebia Therapeutics to Report First Quarter 2019 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, today announced plans . . .
Posted on 4/30/19
Ocular Therapeutix Settles Litigation with Mati Therapeutics
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, . . .
Posted on 4/30/19
Celgene's Final Earnings Report?
As it prepares to be acquired by Bristol-Myers Squibb (NYSE:BMY), Celgene(NASDAQ:CELG) continued its solid performance, racking up double-digit sales growth in the first quarter.Celgene results: The . . .
Posted on 4/30/19
Why Biogen Could Be A Buy At These Levels
SummaryBiogen has yet to recover after discontinuing its drug study for Alzheimer's disease.Compelling valuations.Share buyback and product pipeline are just a few positive catalysts.This idea was . . .
Posted on 4/30/19
Magenta Therapeutics Launches Proposed Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, . . .
Posted on 4/30/19
Repligen Corp. Proposes Public Offering of Shares of Common Stock
WALTHAM, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that it has commenced an underwritten public offering of $175,000,000 in shares . . .
Posted on 4/29/19
Blood Centers of America and Verax Biomedical enter into Group Purchasing Agreement for the use of the Verax Platelet PGD Test
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Verax Biomedical Incorporated announced today that it has entered into a three-year group purchasing agreement with Blood Centers of America (BCA) for the company’s . . .
Posted on 4/29/19
Charles River Laboratories Completes the Acquisition of Citoxlab
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Citoxlab for €448 million in cash
Posted on 4/29/19
Paragonix and the Lung Transplant Foundation Announce Expansion of Partnership
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. and the Lung Transplant Foundation (LTF) today announced an expansion of their partnership for the development of a series of innovative . . .
Posted on 4/29/19
Precipio Takes Final Step Towards Regaining Nasdaq Compliance
NEW HAVEN, Conn., April 26, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO) today announced that it has implemented a 1-for-15 reverse stock . . .
Posted on 4/26/19
Bristol-Myers Squibb Co (BMY) Q1 2019 Earnings Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Bristol-Myers Squibb Co (NYSE:BMY)Q1 2019 Earnings CallApril 25, 2019, 10:30 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood day, and welcome to . . .
Posted on 4/26/19
Biogen Looks to 23 Clinical Programs for Growth
Biogen (NASDAQ:BIIB) continues to lean on sales growth of its spinal muscular atrophy drug, Spinraza, to drive revenue. While the overall double-digit revenue growth is nothing . . .
Posted on 4/25/19
Varsity Healthcare Partners Completes Partnership with Angels of Care
STAMFORD, Conn. & LOS ANGELES--(BUSINESS WIRE)--Varsity Healthcare Partners, a leading lower middle-market private equity firm focused on healthcare services, announced today the completion of a growth . . .
Posted on 4/25/19
BV Invests in Franco Signor
BV Investment Partners, a middle-market private equity firm focused on the business services, software and IT services sectors, today announced that it has made an investment . . .
Posted on 4/25/19
Alexion Reports First Quarter 2019 Results
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the first quarter of 2019. Total revenues in the first quarter were $1,140.4 million, a 23 . . .
Posted on 4/25/19
Thermo Fisher Scientific Inc (TMO) Q1 2019 Earnings Call Transcript
Thermo Fisher Scientific Inc (NYSE:TMO)Q1 2019 Earnings CallApril 24, 2019, 8:30 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning, ladies and gentlemen, and welcome to . . .
Posted on 4/25/19
Boston Scientific Disappoints With Its Q1 Earnings Results
The last time Boston Scientific (NYSE:BSX) announced its quarterly results, the company reported good news overall. Revenue increased 6% year over year, while adjusted earnings jumped . . .
Posted on 4/25/19
Biogen Inc (BIIB) Q1 2019 Earnings Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Biogen Inc (NASDAQ:BIIB)Q1 2019 Earnings CallApril 24, 2019, 8:00 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning, my name is Jessa . . .
Posted on 4/24/19
Apothecare Pharmacy Recognizes Autism Awareness Month with $15,000 Gift to Road To Responsibility
In recognition of Autism Awareness Month, Apothecare Pharmacy recently pledged a gift of $15,000 to Road To Responsibility (RTR; http://roadtoresponsibility.org), one of the region’s largest and . . .
Posted on 4/24/19
Casebia Advances Genetic Engineering with New Tools and Techniques
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Casebia Therapeutics, an innovative gene editing company discovering and developing curative treatments for genetic diseases, and the company’s collaborators will be presenting six posters . . .
Posted on 4/24/19
NanoView Biosciences and Quantum Design Japan Enter Into Japanese Distribution Agreement
BOSTON--(BUSINESS WIRE)--NanoView Biosciences, Inc., and Quantum Design Japan, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView platform in Japan.“We . . .
Posted on 4/24/19
BJ’s Charitable Foundation Partners with Boston Children’s Hospital
WESTBOROUGH, Mass.--(BUSINESS WIRE)--BJ’s Wholesale Club (NYSE: BJ) announced a $250,000 grant from the BJ’s Charitable Foundation to support an innovative initiative from Boston Children’s Hospital called . . .
Posted on 4/24/19
Boston Scientific Announces Results For First Quarter 2019
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.493 billion during the first quarter of 2019. This represents growth of 4.8 percent on a reported basis, . . .
Posted on 4/24/19
Thermo Fisher Scientific Reports First Quarter 2019 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2019.First Quarter . . .

